Jul. 28, 2015

Statement on the Results of Epratuzumab Study for the Treatment of Lupus

Results from a study of epratuzumab were released today. It did not meet its primary endpoint of clinically reducing the severity of lupus in people with mild to moderate disease. The following is a statement from Sandra C. Raymond, President and CEO

Jul. 10, 2015

U.S. House of Representatives Passes 21st Century Cures Act

Jul. 01, 2015

Dr. George C. Tsokos Selected as 2015 Recipient of the Lupus Insight Prize

George C. Tsokos, M.D., Chief of the Rheumatology Division at Beth Israel Deaconess Medical Center and Professor of Medicine, Harvard Medical School, has been selected as the 2015 recipient of the Lupus Insight Prize.

Apr. 01, 2015

Preliminary Results Showcase Success of New Lupus Foundation of America Initiative

LFA-REAL aims to improve health and quality of life for people with lupus.

Apr. 01, 2015

People With Lupus Must Have Access to Prescription Drugs

People with lupus need and deserve a full arsenal of treatments. With many new and innovative drugs for lupus in the drug pipeline, these highly anticipated treatments will mean nothing if people with lupus cannot afford them.

Jan. 14, 2015

Government Spending Bill Includes Funding for Vital Lupus Programs

Statement from Sandra C. Raymond, President and CEO of the Lupus Foundation of America

Dec. 08, 2014

Lupus Research Studies Widen Understanding

Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.

Nov. 04, 2014

U.S. Department of Defense Announces $3.4 Million to Support Lupus Research

Award is the largest amount allocated to lupus since 2006